U.S. Equity News Features Micro Identification Technologies in the Fight Against Bacteria

Micro Identification Technologies, Inc. (OTCBB: MMTC), a leader in rapid bacterial identification, today announces it was recently featured in an editorial published by U.S. Equity News that covers the history of bacteria, its life threatening effects, and publicly traded companies leading the fight against harmful bacteria.

The entire piece can be found at the following link: http://app.quotemedia.com/quotetools/newsStoryPopup.go?storyId=30329318&webmasterId=89753.

In the editorial U.S. Equity News stated, “Although giant pharmaceutical companies remain the biggest players in the war against bacteria, one of the most unique breakthroughs in the science belongs to a little company out of San Clemente, California called Micro Identification Technology (“MIT”). The company has developed a way to identify 23 different species of pathogenic bacteria, just minutes after completed culturing. It's all done by laser light that is scattered off bacteria cells suspended in water, creating light patterns that are unique for each bacteria species.”

Micro Identification's Chief Executive Officer, Michael Brennan, commented on the editorial, “With thousands of people dying each year from harmful bacteria, this article represents the importance of detecting pathogenic bacteria early. We are proud to have been featured in such a prestigious news source.”

Mr. Brennan continued, “Our laser-based microbial identification technology makes it possible to rapidly process thousands of samples for pennies on the dollar when compared to the traditional laboratory process; which could effectively save millions in bacterial analysis and healthcare costs. Since our breakthrough method of identification doesn’t rely on chemical or biological processing, fluorescent tags, gas chromatography or DNA analysis, we can produce accurate results in a fraction of the time. We are well positioned for immense growth as the knowledge of our technology spreads and hospitals and clinics across the country find new ways to cut costs while still delivering excellent service to their patients.”

About Micro Identification Technologies (MIT):

MIT is a developer of patented technologies for rapid bacterial identification, a process that is significantly different from all other bacterial Identification methods and is not reliant on chemical or biological processing, fluorescent tags, gas chromatography or DNA analysis. The MIT 1000 System's process is totally GREEN, requiring only water and unknown bacteria samples.

MIT last year completed an extensive evaluation and certification by the AOAC Research Institute, which included rigorous independent testing and thorough reviews by the AOAC RI and its expert reviewers, including the U.S. Department of Agriculture. The AOAC RI certification is a gold standard in food safety and the Report is available from the Company.

MIT has further demonstrated the ability to detect and identify, within several minutes and at a cost of pennies-per-test, the microbes Escherichia coli, Listeria, Salmonella, Staphylococcus aureus, and other pathogenic bacteria. The MIT 1000 System can currently identify 23 species of bacteria and this identification capability is easily expanded. The process has been verified by North American Science Associates, Inc. (NAMSA), an independent, internationally recognized biological testing laboratory. The NAMSA Test Report, in MIT's opinion, acknowledges the accuracy, speed and cost effectiveness of the System over conventional processes and is available from the Company.

Further information is available from MIT's SEC filings and its web site http://www.micro-identification.com.

This release contains statements that are forward-looking in nature. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions are forward-looking statements. These statements are made based upon information available to the Company as of the date of this release, and we assume no obligation to update any such forward-looking statements. These statements are not guarantees of future performance and actual results could differ materially from our current expectations. Factors that could cause or contribute to such differences include, but are not limited to dependence on suppliers; short product life cycles and reductions in unit selling prices; delays in development or shipment of new products; lack of market acceptance of our new products or services; inability to continue to develop competitive new products and services on a timely basis; introduction of new products or services by major competitors; our ability to attract and retain qualified employees; inability to expand our operations to support increased growth; and declining economic conditions, including a recession. These and other factors and risks associated with our business are discussed from time to time within our filings with the Securities and Exchange Commission.

Micro Imaging Technology (CE) (USOTC:MMTC)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024